Latest news with #TDI
Yahoo
27-05-2025
- Business
- Yahoo
Gujarat Narmada Valley Fertilizers & Chemicals Ltd (BOM:500670) Q4 2025 Earnings Call ...
Release Date: May 26, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. The board of directors has recommended a dividend of 180%, an increase from the previous 165%. The company has a significant capital expenditure plan of around 2,900 crore at various stages of execution, aimed at improving efficiency and cost savings. Sales volume growth was reported across several products, with notable increases in TGUa (52%), Aniline (15%), and Formic Acid (6.7%). The chemical segment showed strong performance, contributing positively to the company's profitability. The company is working on strategic initiatives to optimize procurement and power costs, which could lead to future cost savings. The company experienced an elongated shutdown of the TDI 2 plant, resulting in a loss of approximately 300 crore in revenue and 100 crore in profits. There was a net loss of roughly 100 crore in other comprehensive income due to a decline in the prices of listed investments. The TDI production was down by 44% due to the extended shutdown, impacting overall production volumes. Input cost advantages from reduced petrochemical prices were offset by pricing pressures on TDI output. The company anticipates limited volume growth in FY 526 due to a planned three-week shutdown at the beginning of the financial year. Warning! GuruFocus has detected 5 Warning Signs with BOM:500670. Q: What was the sales volume growth for Gujarat Narmada Valley Fertilizers & Chemicals Ltd in FY 2025, and which products contributed to this growth? A: The sales volume was 7% higher than FY 2024. Specific product contributions included a 9% increase in sales, a 15% increase in aniline sales, a 52% increase in TGU sales, a 15% increase in CNS sales, and a 6.7% increase in formic acid sales. Methanol sales also increased by 7%. Q: Are there any planned shutdowns for FY 2026, and which products are expected to see volume growth? A: A shutdown occurred at the beginning of the current financial year for about three weeks, limiting volume growth potential. No further shutdowns are planned for the rest of FY 2026. Q: How did the extended shutdown of the TDI plant affect production and what are the expectations for FY 2026? A: The production was down by 31% due to the shutdown, with TDI volumes specifically down by 44%. For FY 2026, the company does not foresee major issues and expects to achieve installed capacity production. Q: What is the impact of the reduction in toluene prices on the company's financials? A: While there has been a reduction in toluene prices, the benefit is offset by pricing pressure on TDI, which affects the input cost advantage. Q: What are the expected benefits from the commissioning of the new boiler in FY 2026? A: The commissioning is expected by September 2025, with an anticipated cost advantage ranging between ?12,000 to ?18,000 per metric ton, depending on gas and coal prices. This could help reduce losses at the PBT level for TDI. Q: Can you provide insights into the strategic initiatives for cost reduction and efficiency improvement? A: Initiatives include procurement optimization, power optimization through increased renewable energy use, and digital initiatives. These are expected to have varying timelines for impact, ranging from 6 months to 4 years. Q: What are the production numbers for ammonia and weak nitric acid for FY 2026? A: Ammonia production from oil was 336,000 tons and from gas was 369,000 tons. Weak nitric acid production was approximately 443,000 tons. Q: What is the status of the expansion plans recommended by Kearney, and what is the investment size? A: The company is considering an investment size of up to ?22,000 crore for new projects, which are mostly import substitutes. Detailed feasibility reports are being prepared to assess the return profile of each product. Q: How does the company plan to manage maintenance CapEx and what is the expected CapEx for FY 2026? A: Maintenance CapEx is expected to be more than ?200 crore annually. The total CapEx for FY 2026 includes ?300 crore for ongoing projects, excluding maintenance CapEx. Q: What is the outlook for methanol production given the current economic conditions? A: Methanol production was profitable for 7-8 months due to competitive gas prices. However, with rising gas prices since December, the plant is currently not in operation. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
16-05-2025
- Business
- Yahoo
Nuance seeks China approval for Ohtuvayre following Phase III trial success
Nuance Pharma's Ohtuvayre (ensifentrine) has met the primary endpoint in a Phase III chronic obstructive pulmonary disease (COPD) study in China. The medication was developed as part of a partnership with UK company Verona Pharma. In the ENHANCE-CHINA trial (NCT05743075), nebulised Ohtuvayre showed a statistically significant and clinically meaningful improvement in change in forced expiratory volume (FEV) of 110ml after 12 weeks. The trial also showed improvement in lung function, including a peak FEV of 174mL, a morning trough FEV increase of 36ml and an evening trough FEV increase of 65ml. Patients also receiving saw a 28% reduction in the rate of moderate/severe COPD exacerbations over 24 weeks, and there was a decrease in the risk of a moderate/severe exacerbation, measured by time to first exacerbation of 25%. There was also improvement in secondary endpoints, including dyspnea as measured by the Transition Dyspnea Index (TDI) of 0.8 compared to placebo over 24 weeks. Quality of Life (QoL), as measured by the St George's Respiratory Questionnaire (SGRQ) Total Score in the Ohtuvayre arm, also improved by -2.9, higher than the Minimal Clinically Important Difference (MCID) of -4. The therapy remained well-tolerated with adverse event (AE) incidence similar to placebo. Nuance Pharma CEO Mark Lotter said: "These promising results demonstrate Ohtuvayre's strength as a first-in-class bronchodilator and non-steroidal anti-inflammatory therapy for COPD, as an advance to existing treatment options.' Nuance Pharma plans to submit a new drug application to China's National Medical Products Administration (NMPA) in the second half of 2025. Shanghai-based Nuance gained rights to Ohtuvayre in June 2021 after signing a $219m strategic collaboration with Verona Pharma. The collaboration gave Nuance Pharma development and commercial rights in Greater China. Ohtuvayre is a first-in-class selective dual inhibitor of phosphodiesterase 3 and 4 (PDE3 and PDE4) that combines bronchodilator and non-steroidal anti-inflammatory effects delivered through a standard jet nebuliser. The drug was approved by the US Food and Drug Administration (FDA) on 26 June 2024 for use in adult COPD patients. Approval for use in Europe has yet to be granted. Nuance Pharma plans to release additional information from ENHANCE-CHINA at upcoming scientific conferences. According to GlobalData, Ohtuvayre could reach global sales of $1.63bn in 2030. GlobalData is the parent company of Clinical Trials Arena. "Nuance seeks China approval for Ohtuvayre following Phase III trial success" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
The Citizen
10-05-2025
- Automotive
- The Citizen
VW Amarok Life targets Ford Ranger XLT and Toyota Hilux Raider
New bakkie model comes standard with alloy wheels, LED lights and smartphone integration. The VW Amarok Life is built alongside the Ford Ranger in Silverton. Picture: Volkswagen Volkswagen has added a new derivative to the VW Amarok bakkie line-up to go head-to-head with the Ford Ranger XLT and Toyota Hilux Raider. The new model is the 125kW VW Amarok Life 2.0 TDI which only comes with a 4×2 drivetrain and is mated to a six-speed automatic transmission. VW Amarok Life well-specced Just like the Ford Ranger and Toyota Hilux it is up against, the new VW Amarok comes packed with a range of practical and premium features despite not being a top-of-the-range derivative. These include 17- ch Combra alloy wheels, power tailgate lock, trailer hitch and front and rear park distance control including a fixed rear-view camera. Six tie-down hooks and integrated cargo lights feature on the sides of the loadbox, making it ideal for both family and work-related tasks. ALSO READ: Powerful LDV bakkie slayed by VW Amarok, Ranger, Hilux and D-Max Inside, the Amarok Life features seat trim covers finished in durable fabric and an 8 inch multifunction display with radio, six speakers, and Bluetooth connectivity. Smartphone integration is seamless thanks to App-Connect (Apple CarPlay and Android Auto). The VW Amarok Life includes a leather-wrapped multifunction steering wheel and cruise control with a speed limiter. Safety is a priority, with LED headlights and daytime running lights, as well as driver and front passenger airbags. Frugal sipper The 2.0 TDI offers 125kW of power and 405Nm of torque from its four-cylinder single-turbo diesel powertrain. Claimed top speed comes in at 180km/h with the fuel consumption number set at 6.9 litres per 100km. The VW Amarok Life 2.0 TDI costs R704 700. Its two main rivals, the Ford Ranger 2.0 SiT XLT and Toyota Hilux 2.4 GD-6 Raider cost R681 500 and R633 200 respectively The VW Amarok comes standard with a five-year/150 000km warranty and also a five-year/100 000km Genuine Easy Drive maintenance plan.
Yahoo
29-04-2025
- Business
- Yahoo
DHL resumes global shipments of packages worth over $800 to US customers
DHL Express is resuming shipments valued at more than $800 to consumers in the U.S. from businesses in other countries. The parcel delivery company announced the move on Monday, marking an end to a temporary pause in business-to-consumer (B2C) shipments of over $800 into the U.S. that it had instituted about a week ago. DHL Express said on its website it has "resumed the transport of B2C shipments addressed to private individuals in the U.S. where the declared value exceeded Usd 800" effective Monday. Courier Firm Dhl Express To Suspend Global Shipments Of More Than $800 To Us Consumers Over New Customs Rules The temporary suspension of $800-plus shipments into the U.S. was precipitated by a regulatory change that subjected such parcels to formal customs clearances, but, according to the parcel delivery company, shipments worth $800 to $2,500 now "can once again be cleared using the expedited informal entry process." Its decision to restart the shipments "follows constructive dialogue between DHL and the U.S. government, who demonstrated a strong willingness to understand our operational and technical challenges, and who agreed that it was imperative to act quickly in the interest of U.S. consumers," DHL Express said. Read On The Fox Business App The company noted to customers that they could still encounter delays with their shipments into the U.S. while it resumes the service and works through its backlog. "DHL Express values the opportunity to have contributed to the development of this new regulation by the U.S. government in favor of our customers, who have been our focus," the company said. "It is our priority to effectively support your needs, and we view this development as a positive step forward in continuing the facilitation of international trade." DHL Express, part of the larger Germany-based DHL Group, largely focuses on "Time Definite International" services. Globally, it notched roughly 276 million TDI shipments last year, according to the company. Click Here To Read More On Fox BusinessOriginal article source: DHL resumes global shipments of packages worth over $800 to US customers
Yahoo
21-03-2025
- Yahoo
High school coach charged with sex crimes
GRAYSON A Carter County man and staff member of a local high school was jailed on Wednesday on multiple sex crimes, allegedly involving minors. Harlee Estepp, 28, of Grayson, was briefly lodged in Boyd County Detention Center before being transferred to Carter County after a grand jury indicted Estepp this week on two counts of first-degree sexual abuse and procuring a minor child via electronic means. According to social media and numerous news reports, Estepp was the head track and field coach at Ashland Blazer High School, and per previous publications in TDI, was also on coaching staff for the school's football program. Per Estepp's indictment, he allegedly committed two separate instances of sexual abuse by subjecting a minor younger than 16 to sexual contact or 'engag(ed) in masturbation in the presence of the minor,' or 'engag(ed) in masturbation while using the Internet, telephone or other electronic communication device while communicating with a minor.' The class-D felonies occurred between August 2021 and May 2022, records show. A final charge of procuring or promoting a minor via electronic means occurred during the same time frame, where prosecutors allege Estepp utilized the internet or communication device to 'induce the minor to engage in sexual or other prohibited activities,' according to court records. As of this writing, Estepp is still lodged in the Carter County Detention Center and is scheduled for arraignment before Carter Circuit Judge Rebecca Phillips on March 26 at 1 p.m.
